Share Price and Basic Stock Data
Last Updated: October 10, 2025, 8:54 pm
| PEG Ratio | 4.42 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Excel Industries Ltd, a prominent player in the agrochemicals and pesticides industry, is currently priced at ₹1,132 with a market capitalization of ₹1,414 Cr. The company reported a revenue of ₹1,090 Cr for the fiscal year ending March 2023, reflecting a decline from ₹1,178 Cr in the previous year. The quarter-on-quarter sales have shown a consistent downward trend, peaking in June 2022 at ₹329 Cr but tapering to ₹198 Cr by September 2023. This decline in sales raises concerns about the company’s market positioning amidst increasing competition in the agrochemicals sector, which is projected to grow at a CAGR of 10.3% from 2023 to 2028 according to industry sources.
Profitability and Efficiency Metrics
Excel Industries has faced significant challenges in maintaining profitability, as evidenced by its operating profit margin (OPM) dropping to 5% in March 2024 from a high of 20% in March 2022. The net profit for the year ending March 2025 is projected at ₹85 Cr, indicating a slight recovery from ₹80 Cr in March 2023. The company’s return on equity (ROE) stands at a modest 5.21%, while the return on capital employed (ROCE) is at 7.11%, both of which are below industry averages. Additionally, the cash conversion cycle (CCC) remains at 49 days, suggesting a relatively efficient management of working capital compared to the sector average of 60 days, indicating potential for improvement in operational efficiency.
Balance Sheet Strength and Financial Ratios
Excel Industries maintains a robust balance sheet with total reserves of ₹1,582 Cr and minimal borrowings of ₹12 Cr, reflecting a debt-free status. The price-to-book value (P/BV) ratio is 0.62x, indicating that the stock is undervalued compared to its book value, which stands at ₹1,135.23 per share as of March 2024. The interest coverage ratio is exceptionally high at 30.16x, showcasing the company’s ability to service its obligations comfortably. However, the declining trend in net profit and operating profit raises concerns about future profitability. The current ratio of 2.56x suggests a strong liquidity position, which is favorable for addressing short-term obligations.
Shareholding Pattern and Investor Confidence
The shareholding structure of Excel Industries reveals a strong promoter holding at 52.68%, which is a positive indicator of long-term commitment. Foreign institutional investors (FIIs) have gradually increased their stake to 2.08%, while domestic institutional investors (DIIs) hold 6.98%. The public shareholding stands at 38.27%, which reflects a diversified investor base. However, the slight decline in public shareholding from 39.72% in September 2023 to 38.27% in June 2025 could indicate waning investor confidence amid fluctuating performance metrics. Overall, the stability in promoter holdings coupled with a modest increase in institutional participation suggests a cautiously optimistic outlook among investors.
Outlook, Risks, and Final Insight
Looking ahead, Excel Industries faces both opportunities and challenges. The agrochemical market’s growth trajectory provides potential for revenue recovery, but the company must address its declining profitability and operational inefficiencies to leverage this growth. Key risks include market volatility, competition from both domestic and international players, and potential regulatory changes affecting the agrochemical sector. Strengths such as a solid balance sheet, low debt levels, and committed promoters provide a cushion against these risks. In conclusion, while Excel Industries is positioned to benefit from market growth, it must enhance operational efficiency and profitability to capitalize on these opportunities fully.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Excel Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 7,400 Cr. | 1,714 | 2,362/1,502 | 17.2 | 441 | 0.35 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 1,033 Cr. | 306 | 391/165 | 19.7 | 117 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 55.7 Cr. | 107 | 148/55.2 | 10.2 | 34.1 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 3,223 Cr. | 248 | 392/234 | 113 | 53.9 | 0.06 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 829 Cr. | 351 | 670/244 | 12.1 | 320 | 0.86 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,457.65 Cr | 1,527.89 | 35.19 | 435.59 | 0.41% | 15.21% | 19.87% | 7.25 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 329 | 312 | 223 | 226 | 214 | 198 | 180 | 234 | 265 | 269 | 196 | 248 | 310 |
| Expenses | 274 | 279 | 195 | 215 | 207 | 195 | 179 | 221 | 226 | 220 | 184 | 228 | 267 |
| Operating Profit | 55 | 33 | 28 | 11 | 8 | 3 | 1 | 12 | 39 | 49 | 12 | 20 | 42 |
| OPM % | 17% | 10% | 13% | 5% | 4% | 1% | 1% | 5% | 15% | 18% | 6% | 8% | 14% |
| Other Income | 3 | 6 | 2 | 3 | 9 | 7 | 11 | 5 | 11 | 8 | 5 | 6 | 12 |
| Interest | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 |
| Depreciation | 8 | 8 | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 |
| Profit before tax | 50 | 30 | 22 | 5 | 8 | 2 | 4 | 9 | 41 | 47 | 8 | 16 | 44 |
| Tax % | 25% | 25% | 14% | 57% | 24% | 9% | 34% | 25% | 25% | 24% | 26% | 24% | 24% |
| Net Profit | 37 | 22 | 19 | 2 | 6 | 2 | 3 | 7 | 31 | 36 | 6 | 12 | 34 |
| EPS in Rs | 29.47 | 17.53 | 14.86 | 1.72 | 4.68 | 1.42 | 2.13 | 5.31 | 24.68 | 28.38 | 4.93 | 9.87 | 26.86 |
Last Updated: August 20, 2025, 11:00 am
Below is a detailed analysis of the quarterly data for Excel Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 310.00 Cr.. The value appears strong and on an upward trend. It has increased from 248.00 Cr. (Mar 2025) to 310.00 Cr., marking an increase of 62.00 Cr..
- For Expenses, as of Jun 2025, the value is 267.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 228.00 Cr. (Mar 2025) to 267.00 Cr., marking an increase of 39.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 42.00 Cr., marking an increase of 22.00 Cr..
- For OPM %, as of Jun 2025, the value is 14.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Mar 2025) to 14.00%, marking an increase of 6.00%.
- For Other Income, as of Jun 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 6.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 28.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 24.00%.
- For Net Profit, as of Jun 2025, the value is 34.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 34.00 Cr., marking an increase of 22.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 26.86. The value appears strong and on an upward trend. It has increased from 9.87 (Mar 2025) to 26.86, marking an increase of 16.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: May 15, 2025, 6:45 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 416 | 482 | 448 | 462 | 599 | 825 | 702 | 749 | 1,178 | 1,090 | 826 | 978 |
| Expenses | 376 | 409 | 385 | 419 | 474 | 574 | 571 | 628 | 946 | 961 | 801 | 859 |
| Operating Profit | 40 | 72 | 63 | 44 | 125 | 250 | 131 | 122 | 232 | 129 | 25 | 119 |
| OPM % | 10% | 15% | 14% | 9% | 21% | 30% | 19% | 16% | 20% | 12% | 3% | 12% |
| Other Income | 5 | 7 | 3 | 9 | 4 | 5 | 10 | 9 | 15 | 12 | 32 | 30 |
| Interest | 12 | 14 | 13 | 11 | 7 | 3 | 4 | 3 | 3 | 3 | 3 | 2 |
| Depreciation | 11 | 15 | 15 | 14 | 15 | 18 | 23 | 27 | 31 | 31 | 31 | 34 |
| Profit before tax | 21 | 51 | 38 | 27 | 107 | 234 | 115 | 101 | 213 | 106 | 23 | 113 |
| Tax % | 15% | 19% | 31% | 26% | 31% | 34% | 16% | 29% | 24% | 24% | 25% | 24% |
| Net Profit | 18 | 41 | 26 | 20 | 74 | 153 | 96 | 71 | 161 | 80 | 17 | 85 |
| EPS in Rs | 16.50 | 34.59 | 20.18 | 15.93 | 58.78 | 122.07 | 76.42 | 56.55 | 128.23 | 63.59 | 13.53 | 67.86 |
| Dividend Payout % | 23% | 20% | 22% | 38% | 21% | 15% | 13% | 20% | 18% | 18% | 41% | 20% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 127.78% | -36.59% | -23.08% | 270.00% | 106.76% | -37.25% | -26.04% | 126.76% | -50.31% | -78.75% | 400.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -164.36% | 13.51% | 293.08% | -163.24% | -144.01% | 11.21% | 152.80% | -177.07% | -28.44% | 478.75% |
Excel Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | -6% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | -4% |
| 3 Years: | -21% |
| TTM: | 109% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 7% |
| 3 Years: | -5% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 7% |
| 3 Years: | 4% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 3:50 am
Balance Sheet
Last Updated: August 11, 2025, 1:53 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 147 | 180 | 204 | 404 | 526 | 693 | 695 | 845 | 1,143 | 1,235 | 1,421 | 1,582 |
| Borrowings | 102 | 95 | 89 | 68 | 10 | 7 | 24 | 9 | 7 | 3 | 2 | 12 |
| Other Liabilities | 97 | 106 | 121 | 141 | 186 | 209 | 212 | 251 | 330 | 248 | 367 | 319 |
| Total Liabilities | 352 | 387 | 421 | 619 | 728 | 916 | 937 | 1,111 | 1,487 | 1,493 | 1,795 | 1,920 |
| Fixed Assets | 128 | 158 | 164 | 183 | 203 | 238 | 376 | 389 | 427 | 428 | 428 | 459 |
| CWIP | 20 | 3 | 3 | 8 | 23 | 12 | 10 | 17 | 21 | 19 | 19 | 13 |
| Investments | 22 | 23 | 27 | 211 | 282 | 394 | 264 | 365 | 547 | 625 | 984 | 1,085 |
| Other Assets | 181 | 204 | 227 | 216 | 220 | 272 | 287 | 340 | 492 | 421 | 365 | 364 |
| Total Assets | 352 | 387 | 421 | 619 | 728 | 916 | 937 | 1,111 | 1,487 | 1,493 | 1,795 | 1,920 |
Below is a detailed analysis of the balance sheet data for Excel Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,582.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,421.00 Cr. (Mar 2024) to 1,582.00 Cr., marking an increase of 161.00 Cr..
- For Borrowings, as of Mar 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 10.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 319.00 Cr.. The value appears to be improving (decreasing). It has decreased from 367.00 Cr. (Mar 2024) to 319.00 Cr., marking a decrease of 48.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,920.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,795.00 Cr. (Mar 2024) to 1,920.00 Cr., marking an increase of 125.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 459.00 Cr.. The value appears strong and on an upward trend. It has increased from 428.00 Cr. (Mar 2024) to 459.00 Cr., marking an increase of 31.00 Cr..
- For CWIP, as of Mar 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Mar 2024) to 13.00 Cr., marking a decrease of 6.00 Cr..
- For Investments, as of Mar 2025, the value is 1,085.00 Cr.. The value appears strong and on an upward trend. It has increased from 984.00 Cr. (Mar 2024) to 1,085.00 Cr., marking an increase of 101.00 Cr..
- For Other Assets, as of Mar 2025, the value is 364.00 Cr.. The value appears to be declining and may need further review. It has decreased from 365.00 Cr. (Mar 2024) to 364.00 Cr., marking a decrease of 1.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,920.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,795.00 Cr. (Mar 2024) to 1,920.00 Cr., marking an increase of 125.00 Cr..
Notably, the Reserves (1,582.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -62.00 | -23.00 | -26.00 | -24.00 | 115.00 | 243.00 | 107.00 | 113.00 | 225.00 | 126.00 | 23.00 | 107.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 89 | 80 | 103 | 95 | 76 | 70 | 78 | 84 | 62 | 52 | 82 | 81 |
| Inventory Days | 74 | 103 | 99 | 86 | 79 | 75 | 90 | 71 | 103 | 78 | 80 | 70 |
| Days Payable | 81 | 84 | 112 | 98 | 123 | 108 | 122 | 126 | 112 | 64 | 139 | 102 |
| Cash Conversion Cycle | 82 | 99 | 90 | 83 | 32 | 36 | 46 | 29 | 52 | 67 | 23 | 49 |
| Working Capital Days | 17 | 28 | 27 | 42 | 50 | 57 | 49 | 51 | 61 | 61 | 47 | 58 |
| ROCE % | 15% | 24% | 18% | 10% | 22% | 38% | 17% | 13% | 21% | 9% | 2% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 13.53 | 63.59 | 128.24 | 56.55 | 76.43 |
| Diluted EPS (Rs.) | 13.53 | 63.59 | 128.24 | 56.55 | 76.43 |
| Cash EPS (Rs.) | 38.53 | 88.54 | 152.62 | 78.15 | 94.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1135.23 | 987.82 | 914.32 | 677.41 | 557.56 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1135.23 | 987.82 | 914.32 | 677.41 | 557.56 |
| Revenue From Operations / Share (Rs.) | 657.20 | 866.96 | 937.12 | 596.21 | 558.83 |
| PBDIT / Share (Rs.) | 45.07 | 111.10 | 195.73 | 103.53 | 111.57 |
| PBIT / Share (Rs.) | 20.07 | 86.16 | 171.35 | 81.93 | 93.44 |
| PBT / Share (Rs.) | 18.02 | 84.14 | 169.80 | 80.19 | 91.41 |
| Net Profit / Share (Rs.) | 13.53 | 63.59 | 128.24 | 56.55 | 76.43 |
| NP After MI And SOA / Share (Rs.) | 13.53 | 63.59 | 128.24 | 56.55 | 76.43 |
| PBDIT Margin (%) | 6.85 | 12.81 | 20.88 | 17.36 | 19.96 |
| PBIT Margin (%) | 3.05 | 9.93 | 18.28 | 13.74 | 16.72 |
| PBT Margin (%) | 2.74 | 9.70 | 18.11 | 13.45 | 16.35 |
| Net Profit Margin (%) | 2.05 | 7.33 | 13.68 | 9.48 | 13.67 |
| NP After MI And SOA Margin (%) | 2.05 | 7.33 | 13.68 | 9.48 | 13.67 |
| Return on Networth / Equity (%) | 1.19 | 6.43 | 14.02 | 8.34 | 13.70 |
| Return on Capital Employeed (%) | 1.58 | 7.90 | 16.77 | 10.79 | 14.88 |
| Return On Assets (%) | 0.94 | 5.35 | 10.84 | 6.39 | 10.24 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 |
| Asset Turnover Ratio (%) | 0.50 | 0.73 | 0.90 | 0.73 | 0.75 |
| Current Ratio (X) | 2.56 | 3.63 | 2.36 | 2.09 | 1.89 |
| Quick Ratio (X) | 2.03 | 2.56 | 1.55 | 1.65 | 1.37 |
| Inventory Turnover Ratio (X) | 4.09 | 4.14 | 5.31 | 4.90 | 4.52 |
| Dividend Payout Ratio (NP) (%) | 83.13 | 35.38 | 8.77 | 0.00 | 45.35 |
| Dividend Payout Ratio (CP) (%) | 29.19 | 25.41 | 7.37 | 0.00 | 36.65 |
| Earning Retention Ratio (%) | 16.87 | 64.62 | 91.23 | 0.00 | 54.65 |
| Cash Earning Retention Ratio (%) | 70.81 | 74.59 | 92.63 | 0.00 | 63.35 |
| Interest Coverage Ratio (X) | 30.16 | 64.23 | 126.97 | 59.73 | 54.83 |
| Interest Coverage Ratio (Post Tax) (X) | 10.43 | 37.93 | 84.18 | 33.63 | 38.56 |
| Enterprise Value (Cr.) | 878.57 | 914.63 | 1660.75 | 1011.14 | 560.83 |
| EV / Net Operating Revenue (X) | 1.06 | 0.83 | 1.41 | 1.35 | 0.79 |
| EV / EBITDA (X) | 15.51 | 6.55 | 6.75 | 7.77 | 4.00 |
| MarketCap / Net Operating Revenue (X) | 1.08 | 0.91 | 1.46 | 1.41 | 0.79 |
| Retention Ratios (%) | 16.86 | 64.61 | 91.22 | 0.00 | 54.64 |
| Price / BV (X) | 0.62 | 0.80 | 1.50 | 1.24 | 0.80 |
| Price / Net Operating Revenue (X) | 1.08 | 0.91 | 1.46 | 1.41 | 0.79 |
| EarningsYield | 0.01 | 0.07 | 0.09 | 0.06 | 0.17 |
After reviewing the key financial ratios for Excel Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 13.53. This value is within the healthy range. It has decreased from 63.59 (Mar 23) to 13.53, marking a decrease of 50.06.
- For Diluted EPS (Rs.), as of Mar 24, the value is 13.53. This value is within the healthy range. It has decreased from 63.59 (Mar 23) to 13.53, marking a decrease of 50.06.
- For Cash EPS (Rs.), as of Mar 24, the value is 38.53. This value is within the healthy range. It has decreased from 88.54 (Mar 23) to 38.53, marking a decrease of 50.01.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,135.23. It has increased from 987.82 (Mar 23) to 1,135.23, marking an increase of 147.41.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,135.23. It has increased from 987.82 (Mar 23) to 1,135.23, marking an increase of 147.41.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 657.20. It has decreased from 866.96 (Mar 23) to 657.20, marking a decrease of 209.76.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 45.07. This value is within the healthy range. It has decreased from 111.10 (Mar 23) to 45.07, marking a decrease of 66.03.
- For PBIT / Share (Rs.), as of Mar 24, the value is 20.07. This value is within the healthy range. It has decreased from 86.16 (Mar 23) to 20.07, marking a decrease of 66.09.
- For PBT / Share (Rs.), as of Mar 24, the value is 18.02. This value is within the healthy range. It has decreased from 84.14 (Mar 23) to 18.02, marking a decrease of 66.12.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 13.53. This value is within the healthy range. It has decreased from 63.59 (Mar 23) to 13.53, marking a decrease of 50.06.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 13.53. This value is within the healthy range. It has decreased from 63.59 (Mar 23) to 13.53, marking a decrease of 50.06.
- For PBDIT Margin (%), as of Mar 24, the value is 6.85. This value is below the healthy minimum of 10. It has decreased from 12.81 (Mar 23) to 6.85, marking a decrease of 5.96.
- For PBIT Margin (%), as of Mar 24, the value is 3.05. This value is below the healthy minimum of 10. It has decreased from 9.93 (Mar 23) to 3.05, marking a decrease of 6.88.
- For PBT Margin (%), as of Mar 24, the value is 2.74. This value is below the healthy minimum of 10. It has decreased from 9.70 (Mar 23) to 2.74, marking a decrease of 6.96.
- For Net Profit Margin (%), as of Mar 24, the value is 2.05. This value is below the healthy minimum of 5. It has decreased from 7.33 (Mar 23) to 2.05, marking a decrease of 5.28.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 2.05. This value is below the healthy minimum of 8. It has decreased from 7.33 (Mar 23) to 2.05, marking a decrease of 5.28.
- For Return on Networth / Equity (%), as of Mar 24, the value is 1.19. This value is below the healthy minimum of 15. It has decreased from 6.43 (Mar 23) to 1.19, marking a decrease of 5.24.
- For Return on Capital Employeed (%), as of Mar 24, the value is 1.58. This value is below the healthy minimum of 10. It has decreased from 7.90 (Mar 23) to 1.58, marking a decrease of 6.32.
- For Return On Assets (%), as of Mar 24, the value is 0.94. This value is below the healthy minimum of 5. It has decreased from 5.35 (Mar 23) to 0.94, marking a decrease of 4.41.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.50. It has decreased from 0.73 (Mar 23) to 0.50, marking a decrease of 0.23.
- For Current Ratio (X), as of Mar 24, the value is 2.56. This value is within the healthy range. It has decreased from 3.63 (Mar 23) to 2.56, marking a decrease of 1.07.
- For Quick Ratio (X), as of Mar 24, the value is 2.03. This value exceeds the healthy maximum of 2. It has decreased from 2.56 (Mar 23) to 2.03, marking a decrease of 0.53.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.09. This value is within the healthy range. It has decreased from 4.14 (Mar 23) to 4.09, marking a decrease of 0.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 83.13. This value exceeds the healthy maximum of 50. It has increased from 35.38 (Mar 23) to 83.13, marking an increase of 47.75.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 29.19. This value is within the healthy range. It has increased from 25.41 (Mar 23) to 29.19, marking an increase of 3.78.
- For Earning Retention Ratio (%), as of Mar 24, the value is 16.87. This value is below the healthy minimum of 40. It has decreased from 64.62 (Mar 23) to 16.87, marking a decrease of 47.75.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 70.81. This value exceeds the healthy maximum of 70. It has decreased from 74.59 (Mar 23) to 70.81, marking a decrease of 3.78.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 30.16. This value is within the healthy range. It has decreased from 64.23 (Mar 23) to 30.16, marking a decrease of 34.07.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 10.43. This value is within the healthy range. It has decreased from 37.93 (Mar 23) to 10.43, marking a decrease of 27.50.
- For Enterprise Value (Cr.), as of Mar 24, the value is 878.57. It has decreased from 914.63 (Mar 23) to 878.57, marking a decrease of 36.06.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.06. This value is within the healthy range. It has increased from 0.83 (Mar 23) to 1.06, marking an increase of 0.23.
- For EV / EBITDA (X), as of Mar 24, the value is 15.51. This value exceeds the healthy maximum of 15. It has increased from 6.55 (Mar 23) to 15.51, marking an increase of 8.96.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.08. This value is within the healthy range. It has increased from 0.91 (Mar 23) to 1.08, marking an increase of 0.17.
- For Retention Ratios (%), as of Mar 24, the value is 16.86. This value is below the healthy minimum of 30. It has decreased from 64.61 (Mar 23) to 16.86, marking a decrease of 47.75.
- For Price / BV (X), as of Mar 24, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 23) to 0.62, marking a decrease of 0.18.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.08. This value is within the healthy range. It has increased from 0.91 (Mar 23) to 1.08, marking an increase of 0.17.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.01, marking a decrease of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Excel Industries Ltd:
- Net Profit Margin: 2.05%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.58% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.19% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 10.43
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.03
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.4 (Industry average Stock P/E: 35.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.05%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | 184-87, Swami Vivekanand Road, Mumbai Maharashtra 400102 | investors@excelind.com http://www.excelind.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. G Narayana | Chairman Emeritus |
| Mr. Ashwin C Shroff | Executive Chairman |
| Mr. Ravi A Shroff | Managing Director |
| Mr. Hrishit A Shroff | Executive Director |
| Mr. Ninad Gupte | Independent Director |
| Mr. Shekhar Khanolkar | Independent Director |
| Mr. Rajesh Varma | Independent Director |
| Mr. Vihang Virkar | Independent Director |
| Dr. Meena A Galliara | Independent Director |
| Mr. Dinesh Bhagat | Nominee Director |
FAQ
What is the intrinsic value of Excel Industries Ltd?
Excel Industries Ltd's intrinsic value (as of 10 October 2025) is 874.38 which is 23.90% lower the current market price of 1,149.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,447 Cr. market cap, FY2025-2026 high/low of 1,760/798, reserves of ₹1,582 Cr, and liabilities of 1,920 Cr.
What is the Market Cap of Excel Industries Ltd?
The Market Cap of Excel Industries Ltd is 1,447 Cr..
What is the current Stock Price of Excel Industries Ltd as on 10 October 2025?
The current stock price of Excel Industries Ltd as on 10 October 2025 is 1,149.
What is the High / Low of Excel Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Excel Industries Ltd stocks is 1,760/798.
What is the Stock P/E of Excel Industries Ltd?
The Stock P/E of Excel Industries Ltd is 16.4.
What is the Book Value of Excel Industries Ltd?
The Book Value of Excel Industries Ltd is 1,264.
What is the Dividend Yield of Excel Industries Ltd?
The Dividend Yield of Excel Industries Ltd is 1.20 %.
What is the ROCE of Excel Industries Ltd?
The ROCE of Excel Industries Ltd is 7.11 %.
What is the ROE of Excel Industries Ltd?
The ROE of Excel Industries Ltd is 5.21 %.
What is the Face Value of Excel Industries Ltd?
The Face Value of Excel Industries Ltd is 5.00.